In this study, we determined the prevalence of bovine respiratory disease (BRD)-associated viral and bacterial pathogens in cattle and characterized the genetic profiles, antimicrobial susceptibilities, and nature of antimicrobial resistance determinants in collected bacteria. Nasopharyngeal swab and lung tissue samples from 68 BRD mortalities in Alberta, Canada (n ‫؍‬ 42), Texas (n ‫؍‬ 6), and Nebraska (n ‫؍‬ 20) were screened using PCR for bovine viral diarrhea virus (BVDV), bovine respiratory syncytial virus, bovine herpesvirus 1, parainfluenza type 3 virus, Mycoplasma bovis, Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni. Excepting bovine herpesvirus 1, all agents were detected. M. haemolytica (91%) and BVDV (69%) were the most prevalent, with cooccurrence in 63% of the cattle. Isolates of M. haemolytica (n ‫؍‬ 55), P. multocida (n ‫؍‬ 8), and H. somni (n ‫؍‬ 10) from lungs were also collected. Among M. haemolytica isolates, a clonal subpopulation (n ‫؍‬ 8) was obtained from a Nebraskan feedlot. All three bacterial pathogens exhibited a high rate of antimicrobial resistance, with 45% exhibiting resistance to three or more antimicrobials. M. haemolytica (n ‫؍‬ 18), P. multocida (n ‫؍‬ 3), and H. somni (n ‫؍‬ 3) from Texas and Nebraska possessed integrative conjugative elements (ICE) that conferred resistance for up to seven different antimicrobial classes. ICE were shown to be transferred via conjugation from P. multocida to Escherichia coli and from M. haemolytica and H. somni to P. multocida. ICE-mediated multidrug-resistant profiles of bacterial BRD pathogens could be a major detriment to many of the therapeutic antimicrobial strategies currently used to control BRD.
I
n newly received feeder calves, shipping fever or bovine respiratory disease (BRD) is the leading cause of death and illness, contributing to millions of dollars in losses through treatment costs, reduced meat yields, and mortalities (1, 2) . Stressors as a result of weaning, marketing, and transport predispose calves to viral infection that in turn can precipitate bacterial pathogenesis in the lower respiratory tract (3) . Multiple viral and bacterial agents are implicated in BRD, including bovine viral diarrhea virus (BVDV), bovine respiratory syncytial virus (BRSV), bovine herpesvirus 1 (BoHV-1), parainfluenza 3 virus (PI3V), Mannheimia haemolytica, Mycoplasma bovis, Pasteurella multocida, and Histophilus somni. The term bovine respiratory disease can cover a range of pneumonic illnesses, from acute fatal respiratory disease to chronic or prolonged intractable respiratory disease (4). Although not absolute, acute fibrinous pneumonia or acute fatal pneumonia is most commonly associated with M. haemolytica, while chronic caseonecrotic pneumonia is typically associated with M. bovis (5, 6) .
To date, vaccination has shown inconsistent efficacy against M. haemolytica, P. multocida, and H. somni infection in feedlot cattle (7) . As a result, antimicrobials are often the primary management practice used to reduce the incidence of BRD in large feedlots. In western Canada, 20 to 50% of newly arrived feedlot placements receive injectable metaphylactic antimicrobials for BRD prevention (8) , while 75% of U.S. feedlots with capacities of Ͼ8,000 head use injectable antimicrobials at arrival (9) .
As the largest user of antimicrobials worldwide (10) , the agricultural sector is a potential driving force for evolution, persistence, and spread of antimicrobial resistance traits (11) , both in targeted pathogens and commensals of livestock (12) . The use of antimicrobials for growth promotion and metaphylaxis raises concerns over the extent that these practices might contribute to antimicrobial resistance (AMR) in zoonotic bacterial pathogens (13) and reduce the efficacy of antimicrobials employed to control infectious disease in cattle.
Bacteria may be intrinsically resistant or acquire resistance to antimicrobial agents either by de novo mutation in their genomes or through the acquisition of additional genes via horizontal gene transfer through conjugation, transformation, or transduction. Horizontal gene transfer through conjugation requires a multiprotein apparatus, typically synthesized by the donor strain that physically connects the donor and recipient (14) , enabling transfer of one or multiple genes. Typically, conjugation systems employ plasmids or plasmid-derived DNA but recently, chromosome-borne mobile genetic elements referred to as integrative conjugative elements (ICE) have been identified (14) . These elements commonly harbor clusters of accessory genes, including multidrug resistance cassettes accumulated through recombination. Once generated, multidrug-resistant elements can establish and persist in bacterial populations as the result of the use of a single antimicrobial that coselects for the entire element.
The development of widespread resistance in BRD pathogens would be economically devastating to the cattle industry (15) . To ensure prudent antimicrobial use, surveillance of antimicrobial resistance in bacterial agents of BRD is required if therapeutic efficacy is to be maintained. Likewise, it is important to monitor the development of cross-resistance to antimicrobials from drug classes of importance to human medicine.
The objective of this study was to examine BRD mortalities from feedlots in North America for the occurrence of viral and bacterial agents associated with disease and to characterize their antimicrobial resistance profiles.
MATERIALS AND METHODS
Sample collection. Nasopharyngeal swab and lung tissue samples were collected at postmortem necropsy from 68 BRD mortalities presenting acute fibrinous pneumonia in feedlots within Alberta (n ϭ 42), Texas (n ϭ 6), and Nebraska (n ϭ 20). Lung tissue samples consisted of a 4-cm 3 section excised from the perimeter of a pneumonic lesion, stored, and transported in Cary-Blair media (BD Canada, Inc., Mississauga, ON). Nasopharyngeal samples were collected using commercially available deep-guarded culture swabs with a Cary-Blair agar reservoir (BD Canada, Inc., Mississauga, ON). Samples were stored at 4°C for a period no longer than 10 days prior to processing for bacterial isolation.
Bacterial isolation of M. haemolytica, P. multocida, and H. somni. For each lung tissue sample, approximately 2 cm 3 was excised with a sterile scalpel and homogenized with 10 ml of sterile brain heart infusion (BHI) broth (BD Canada, Inc., Mississauga, ON) in a stomacher (Stomacher 400 Circulator; Seward Laboratory Systems, Inc.) for 30 s. A 500-l aliquot of the stomacher suspension was serially diluted 1:10, with 10
Ϫ1
and 10 Ϫ2 dilutions cultured onto tryptic soy agar (TSA) (BD Canada, Inc., Mississauga, ON) plates containing 5% blood overnight at 37°C. An aliquot of the lung tissue stomacher suspension was stored in 20% glycerol at Ϫ80°C and later processed for the isolation of H. somni. For this, approximately 10 l of the frozen stocks was used to inoculate 900 l of BHI broth. A 100-l aliquot of the resulting suspension was plated onto TSA plates containing 5% blood and incubated for 48 h at 37°C in 5% CO 2 .
Colonies displaying morphology indicative of M. haemolytica (i.e., white-gray, round, medium-sized, and nonmucoid and exhibiting ␤-hemolysis) were confirmed as previously described (16) . Identities of colonies displaying morphology of P. multocida (translucent, grayish in color, and mucoid in consistency) and H. somni (yellowish hue and hemolytic) were confirmed by PCR using HotStarTaq Plus master mix (Qiagen Canada, Inc., Toronto, ON) according to manufacturer's specifications, with primers and annealing conditions as described (Table 1) . Colonies exhibiting morphologies not indicative of M. haemolytica, P. multocida, or H. somni were coisolated and the genus/species identified based on DNA sequencing (Eurofins MWG Operon, Huntsville, AL) and BLAST analysis of 16S rRNA genes.
DNA and RNA extractions. Total DNA and RNA were extracted from lung tissue samples using the QIAamp DNA tissue kit and RNeasy Minikit (Qiagen Canada, Inc., Toronto, ON), respectively, according to the manufacturer's specifications and stored at Ϫ80°C until used. Total nucleic acid (DNA extraction without RNase treatment) was extracted from nasopharyngeal swabs using the following procedures. Nasopharyngeal swabs were centrifuged at 13,000 ϫ g for 5 min and the supernatant was aspirated. The swab was removed from the applicator and left inside the tube containing the pellet, resuspended in 180 l of enzymatic lysis buffer, and incubated for 30 min at 37°C. A 25-l aliquot of proteinase K and 200 l of buffer AL (provided with kit) were added to the suspension and incubated at 56°C for 30 min. A sterile steel ball was added to the tube and samples were processed for 1 min at 30 Hz using a tissue lyser (Qiagen Canada, Inc., Toronto, ON). A 200-l volume of ethanol (96 to 100%) was added and the suspension centrifuged at 8,000 ϫ g for 5 min to pellet debris. The supernatant was passed through a DNeasy spin column and nucleic acids were eluted as described in the kit protocol. Samples were stored at Ϫ80°C until used.
Viral and bacterial pathogen detection. All viral and bacterial agents were detected by PCR using master mixes according to the manufacturer's specifications and primers and annealing temperatures listed in Table 1 .
An overall profile of respiratory tract occurrence was generated with an animal identified as positive if the agent was detected in the nasopharynx, lung, or both. Lung DNA and nasopharyngeal nucleic acid extractions were used as the templates for PCR detection of Mannheimia spp., P. multocida, and H. somni; nested PCR detection of BoHV-1; and real-time PCR detection employing TaqMan Fast Universal PCR master mix (Life Technologies, Inc., Burlington, ON) of M. bovis (17) . Lung RNA and nasal nucleic acid extractions were used as the templates for PCR detection of BVDV, BRSV, and PI3V, employing a SuperScript III one-step reverse transcription (RT)-PCR system (Life Technologies, Inc., Burlington, ON) for reverse transcription, followed by a nested PCR. A HotStar HiFidelity polymerase kit (Qiagen Canada, Inc., Toronto, ON) was used for nested PCR of BVDV reverse transcription products, with generated amplicons sequenced (Eurofins MWG Operon, Huntsville, AL) and analyzed using Geneious R6 version 6.0.5 (Biomatters, Ltd., Auckland, New Zealand). Alignments generated in BLAST were used for identification of BVDV subspecies 1 and 2.
DNA extracted from the following strains was used for bacterial positive controls: Pasteurella multocida subsp. multocida strain 17976B (CCUG), M. haemolytica strain BAA-410 (ATCC), Histophilus somni strain 700025 (ATCC), and Mycoplasma bovis strain 25523 (ATCC). Positive controls for viral agents were prepared by cloning specific PCR products into plasmids using the first-round PCR primers listed in Table 1 . Amplicons generated from nucleic acids extracted from viral strains (BVDV1, Singer strain; BVDV2, Ames 125-C strain; BoHV-1, Colorado-34 strain) or positive nasopharyngeal/lung samples (BRSV and PI3V) were cloned into a TA vector pCR2.1 (Life Technologies, Inc., Burlington, ON). Cloned fragments were confirmed by sequencing.
Statistical analysis. Pearson correlation analysis (SAS System for Windows, release 9.1.3; SAS Institute, Cary, NC) was used to determine the correlation between PCR results from nasopharyngeal and lung tissue samples for all bacterial and viral agents examined in this study, and differences were considered significant at a P value of Ͻ0.01.
Serotyping. Mannheimia haemolytica isolates were serotyped using the rapid plate agglutination procedure with rabbit antisera raised against reference strains of M. haemolytica as previously described (18) .
Pulsed-field gel electrophoresis. Molecular typing was performed on all isolates of M. haemolytica, P. multocida, and H. somni by pulsed-field gel electrophoresis (PFGE) according to previous methods (18) . Macrorestriction digests were completed using SalI for M. haemolytica, ApaI for P. multocida, and SacII for H. somni. Electrophoresis conditions for all three species employed a program of 6 V/cm for 22 h at 12°C with switch times from 4 to 40 s. Pulsed-field profile and statistical analyses were performed using BioNumerics V5.1 software (Applied Maths, Inc., Austin, TX).
Broth microdilution assay. Antimicrobial susceptibility testing was performed on M. haemolytica, P. multocida, and H. somni isolates by broth microdilution using a commercially available panel (bovine/porcine with tulathromycin MIC format, Sensititre; Trek Diagnostic Systems, Cleveland, OH), as previously described for M. haemolytica (19) and according to manufacturer's specifications for P. multocida and H. somni. MIC was assigned by the unaided eye as outlined in the Clinical and Laboratory Standards Institute document M31-A3 (20) . Clinical and Laboratory Standards Institute (20) breakpoints were not available for clindamycin, ampicillin, penicillin, gentamicin, neomycin, tiamulin, sulfadimethoxine, trimethoprim-sulfamethoxazole, or tylosin tartrate. Consequently, susceptibility designations for these drugs were not assigned. Exceptions were made in cases in which ampicillin, penicillin, neomycin, or gentamicin MIC distributions for the populations were bimodal and isolates exhibited high MICs and harbored corresponding antimicrobial resistance gene determinants. In these instances, isolates were classified as resistant. In addition, the resistance breakpoint for spectinomycin (Ն128 g/ml) was greater than that evaluated by the panel (maximum concentration evaluated was 64 g/ml). As a result, isolates were classified as spectinomycin 
tet(H)_F/tet(H)_R
ATACTGCTGATCACCGT/TCCCAATAAGCGACGCT resistant if they exhibited a high MIC and harbored a corresponding antimicrobial resistance gene determinant. Screening for resistance determinants and integrative conjugation elements. PCR was used to screen for resistance gene determinants and integrative conjugation element (ICE)-associated genes from ICEPmu1 in isolates of M. haemolytica, P. multocida, and H. somni. All PCRs used heat-lysed colony suspension as the template and primers and annealing conditions described in Table 1 . Representative PCR products were sequenced to confirm the accuracy of amplified fragments.
Bacterial conjugation assay. Conjugal mating experiments were performed to examine the mobility of ICE among isolates of M. haemolytica, P. multocida, and H. somni. Spontaneous rifampin-resistant (Rif r ) isolates for P. multocida strain 17976B and Escherichia coli strain K-12 were generated by selecting and purifying colonies on brain heart infusion (BHI) or Luria-Bertani (LB) (BD Canada Inc., Mississauga, ON) agar plates, respectively, containing 25 g/ml rifampin. The Rif r P. multocida was used as a recipient for M. haemolytica and H. somni donor strains while Rif r E. coli was used as a recipient for P. multocida donor strains. Overnight cultures of donor and recipient strains were grown at 37°C on TSA plates containing 5% blood and mating assays were performed as previously described (21) . Representative colonies of resulting transconjugants were streak purified twice before the transfers of resistance-conferring elements were verified by susceptibility testing and PCR screening for resistance determinants and ICE-associated genes from ICEPmu1. To ensure that transconjugants were not spontaneously resistant donor cells, they were characterized by PCR using the species-specific primers listed in Table 1 .
RESULTS
Bacterial and viral pathogen detection. For the detection of bacterial and viral pathogens implicated in BRD (Table 2 ) (BVDV, BRSV, BoHV-1, PI3V, Mannheimia spp., M. bovis, P. multocida, and H. somni), nucleic acid extractions from lung tissue and nasopharyngeal swabs were screened by PCR and used to generate an overall profile of respiratory tract occurrence. Samples were identified as positive if the viral or bacterial agent was detected in the nasopharynx, lung, or both. Mannheimia spp. were present in 91% of cattle, followed by BVDV (69%), with the subspecies BVDV1 accounting for 77% of BVDV positives. BVDV2 was observed in 26% of cattle, with all BVDV2 containing samples originating from Alberta. One animal screened positive for both BVDV subspecies, with BVDV2 detected in the nasopharynx and BVDV1 detected in the lung. Mycoplasma bovis (63%) and H. somni (57%) were detected in more than half of the mortalities, followed by BRSV (19%), PI3V (13%), and P. multocida (13%). BoHV-1 was not detected in any of the samples. Significant positive correlations were found between PCR results from nasopharyngeal swab and lung tissue samples in individual animals for Mannheimia spp. (r ϭ 0.391, P ϭ 0.0011), P. multocida (r ϭ 0.531, P Ͻ 0.0001), M. bovis (r ϭ 0.395, P ϭ 0.0010), and BVDV (r ϭ 0.630, P Ͻ 0.0001).
Coexistence of multiple pathogens was found in 97% of BRD cases, with Mannheimia spp., BVDV, and M. bovis cooccurrence most frequently identified (16.2%), followed by Mannheimia spp., BVDV, M. bovis, and H. somni cooccurrence (11.8%) and Mannheimia spp. and BVDV cooccurrence (10.3%) (Fig. 1) . Overall, the most prevalent pathogens identified together were Mannheimia spp. and BVDV, present in 63% of the cattle studied.
Bacterial species that were identified by their 16S rRNA sequences but not part of the BRD complex included Bacillus spp., Psychrobacter spp., E. coli, Carnobacterium spp., Enterobacter spp., Trueperella pyogenes, Pantoea agglomerans, Comamonas spp., Aeromonas spp., Alcaligenes spp., Arthrobacter oxydans, Lactobacillus sakei, Pasteurella trehalosi, Proteus mirabilis, Staphylococcus vitulinus, and Streptococcus uberis (data not shown).
Isolate recovery and characterization. Single isolates of M. haemolytica (n ϭ 55), P. multocida (n ϭ 8), and H. somni (n ϭ 10) were recovered from lung tissue samples (Table 2) . From the 55 (50) 10 (15) a Total PCR detection data and data broken down by sample origin are overall respiratory tract profiles, positive if agent was present in either nasopharyngeal swab sample or lung tissue sample or both. Detection in both sample types represents the number of positive animals with the PCR-detected agent in both nasopharyngeal swab and lung tissue samples. Culture data represent isolates recovered from lung tissue samples.
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February 2014 Volume 52 Number 2 jcm.asm.org 441 M. haemolytica isolates collected across North America, 80% (n ϭ 44) were serotype 1, 3.6% (n ϭ 2) were serotype 2, and 16.3% (n ϭ 9) were serotype 6. PFGE analysis identified a clonal subpopulation of M. haemolytica (n ϭ 8) in isolates originating in Nebraska (Fig. 2) (MH09, MH11, MH31, MH34, MH35, MH42, MH44, and MH08). Antimicrobial resistant isolates of P. multocida were found in cattle from Texas, Nebraska, and Alberta and shared Ͼ70% genetic relatedness (Fig. 3A) . Isolates of H. somni from Alberta and Texas exhibited nearly identical pulsotypes (Fig. 3B) . Susceptibility testing showed 72% of M. haemolytica and 50% of P. multocida isolates were antimicrobial resistant. Of these, 30% of M. haemolytica (Fig. 2) (n ϭ 16) and 12.5% of P. multocida (Fig.  3a) (n ϭ 1) were resistant to more than seven antimicrobial classes, including aminoglycosides, penicillins, fluoroquinolones, lincosamides, macrolides, pleuromutilins, and tetracyclines. All multidrug-resistant isolates originated from samples collected in Texas or Nebraska. Antimicrobial-resistant phenotypes were observed in multiple M. haemolytica populations with pulsotypes ranging in similarity from 65 to 100% (Fig. 2) , indicating that resistance was not spread strictly by clonal dissemination. All antimicrobial resistance phenotypes observed corresponded with PCR-positive results for the ICE-associated genes from ICEPmu1 listed in Table 1 , with the exception of two P. multocida isolates for which a determinant for ceftiofur resistance was not identified.
Antimicrobial susceptibility testing of H. somni isolates produced inconsistent results and therefore, only genotypic analyses were reported (Fig. 3) . PCR for resistance determinants revealed four isolates harboring multiple resistance genes (HS45, HS56, HS25, and HS33) (Fig. 3B) and one isolate exhibiting a gene profile similar to that of the multidrug-resistant isolates of M. haemolytica and P. multocida described above (HS33) (Fig. 3B) .
Conjugal transfer of ICE/mobile genetic elements. Mating assays were used to assess the transfer of mobile genetic elements conferring multidrug resistance from isolates of M. haemolytica (n ϭ 25) and H. somni (n ϭ 4) to an Rif r strain of P. multocida and from P. multocida (n ϭ 3) to an Rif r strain of E. coli (Table 3 ). All but eight matings successfully generated transconjugant colonies. Susceptibility testing and PCR were used to confirm phenotypes and genetic transfer of resistance determinants and ICE-associated genes from ICEPmu1 to transconjugants. In 21 of 24 successful transformations, all resistance phenotypes and associated resistance genes were transferred, excepting danofloxacin. It is possible that the danofloxacin resistance determinant was not located on the ICE or was not functional in transconjugants. In instances where successfully transformed recipients differed from the profiles of the donors, two transconjugants acquired all genes and corresponding resistance phenotype with the exception of the bla ROB-1 gene and associated ampicillin and penicillin resistance (MH24 and MH5) ( Table 3) . One transconjugant acquired all resistance phenotypes with the exception of ceftiofur, which was observed in the donor P. multocida strain (PM22) ( Table 3 ). In the eight cases where matings were unsuccessful, one donor isolate (MH8) ( Table 3) had the full complement of ICE-associated genes from ICEPmu1, six of the donor isolates (Table 3) (MH2, MH25 ( Table 3) did not contain the multicopper oxidase gene. However, two isolates with a partial complement of ICE-associated genes from ICEPmu1 (containing three of the five screened genes: multicopper oxidase, transposase tnpA, and single-stranded DNAbinding protein) were successfully transferred (MH54 and MH24) ( Table 3) .
DISCUSSION
With the exception of a few cases (4, 22, 23) , epidemiological data associated with acute BRD mortalities seldom include the complete range of agents that can play a role in the disease. Further, the prevalence of agents is often highly variable within individual cases, likely due to the multiple factors involved in BRD pathogenesis. Consistently, in all studies, including ours, M. haemolytica has been the predominant pathogenic agent detected, and is often identified in mixed infections with M. bovis and BVDV (4, 23, 24) .
The occurrence of BVDV in this study was slightly higher than expected. Administrations of modified live vaccines are a potential source of false-positive data if the duration between vaccination and testing is too short and the vaccine virus is still detectible by PCR. Although the majority of the cattle in this study received a modified live vaccine, more than 90% were sampled at least 7 days after the vaccine was administered upon entry to the feedlot. Persistently infected (PI) cattle are also known to be a primary source of BVDV exposure, leading to seroconversion in over 80% of previously virus-free calves postcontact (25) . Although not screened for in the feedlots sampled, PI animals could have contributed to the increased occurrence of BVDV seen here. It was also interesting to note that all cases of BVDV2 were found in Alberta when BVDV2 has been detected in 27.9% of U.S. stocker calves with acute respiratory disease in the past (22) , and others have shown that BVDV2 accounts for a substantial portion of the North American BVDV population (26) . It is possible that the failure to detect BVDV2 in U.S. BRD mortalities reflects a lower prevalence rate of BVDV2 in the United States than in Canada. It is also possible those data are a result of the restricted sample size, a limitation of the PCR to identify cattle infected with multiple strains of BVDV, or the result of the use of BVDV2-based modified live vaccines in Alberta but not U.S. feedlots. Compared to previous investigations (23, 27) , the occurrence of P. multocida was lower than anticipated, but it is acknowledged that P. multocida plays a significant role in dairy calf pneumonia and in subacute/chronic bronchopneumonia (28, 29) and less of a role in acute fibrinous pneumonia in feedlot calves. Despite selection for fibrinous pneumonia cases, M. bovis and H. somni were isolated at higher rates than expected, comparable to those detected in chronic and bronchiolar pneumonia cases in Alberta (4). Likewise, the prevalence of BSRV in the current study was more similar to that reported in subacute pneumonia (4). In the past 5 years, chronic pneumonia has accounted for an increasing proportion of reported BRD cases (6) and it is not uncommon to see both fibrinous and caseonecrotic pneumonia occurring simultaneously within the same individual (5). Additionally, coisolation of multiple respiratory pathogens is commonly reported in BRD diagnostic investigations (4, (22) (23) (24) . Thus, the elevated detection of some pathogens not typically associated with fibrinous pneumonia may not be surprising.
The only viral pathogen tested for but not detected in this study was BoHV-1. Previously, BoHV-1 has been reported in up to 10% of BRD cases (4, 23) . However, if calves had been infected with BoHV-1 prior to sampling, the virus may not have been detected as it persists latently in the sensory neurons of the trigeminal ganglia or tonsils (30) and is undetectable in nasal mucus postinfection (31) . Our limited sample size may also have contributed to our low level of detection of this pathogen.
Previously, ribotyping of P. multocida obtained from nasal and tracheal swabs of calves with BRD found that 70% of the isolates obtained from these two locations were genetically identical (32) and Timsit et al. (33) recently found that 77% of M. haemolytica collected from the nasopharynx and trans-tracheal aspirations had identical PFGE profiles. Here, we were interested to see if nasopharyngeal swabs could serve as a reliable and economical alternative to lung tissue to detect both viral and bacterial agents implicated in BRD using PCR. Comparisons of PFGE profiles or DNA sequences from M. haemolytica and BVDV, respectively, collected from both the nasopharynx and lungs of individual animals, revealed that in over 80% of cases the agents were identical (data not shown). Further, high concordance was observed between nasopharyngeal swabs and lung tissue for PCR detection of Mannheimia spp. and BVDV, indicating that nasopharyngeal swabs may provide a representative profile of the involvement of these agents in acute BRD mortalities.
Between 2000 and 2009, overall decreases in the susceptibility of M. haemolytica to danofloxacin, tilmicosin, tulathromycin, enrofloxacin, and florfenicol have been observed, with the latter two antimicrobials in particular associated with increased resistance in H. somni (34) . Over time, the MICs of tetracycline, tilmicosin, and tulathromycin have also been increasing for H. somni (34) , whereas bovine-sourced P. multocida has shown reduced susceptibility to florfenicol, spectinomycin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole (27) . Consistent with these trends, the present study revealed a high overall rate of antimicrobial resistance. Seventy-two percent of M. haemolytica isolated in this study were antimicrobial resistant, about twice the percentage detected for M. haemolytica isolated from the nasopharynx of cattle displaying BRD (35%) in a previous study from our group (19) . Furthermore, evidence for multidrug resistance against more than three antimicrobials was found in 45% of the isolates collected during this project, results agreeing with reports that multidrug resistance in BRD pathogens is on the increase (35) (36) (37) .
Recently, an isolate of P. multocida originating from a beef calf in Nebraska was shown to harbor an ICE (ICEPmu1) that carried 11 resistance determinants (38) . The similarity between the antimicrobial-resistant phenotypic profile of that ICEPmu1 isolate and the profiles of isolates recovered in this study prompted the search for and subsequent detection of ICE in M. haemolytica, P. multocida, and H. somni. Integrated conjugative elements are a diverse group of mobile genetic elements found in both Grampositive and Gram-negative bacteria, including Proteobacteria, Actinobacteria, and Firmicutes. Although resident in the host chromosome, ICE retain the machinery required for excision and conjugal transfer (14) . These elements contribute to the horizontal transfer of accessory genes that can bestow traits of antibiotic and heavy-metal resistance, virulence, biofilm formation, nitrogen fixation, and metabolic adaptation (14, 39) . The modular structure of ICE with tandem arrays of closely related elements promotes generation of novel ICE through module swapping and recombination (14) . Certain ICE families employ processes such as toxin-antitoxin systems to prevent their loss, ensuring reintegration back into the donor cell after conjugation has occurred (40) . Integrated conjugative elements have been detected in H. somni with accessory genes for heavy metal and toxin resistance (21) , but prior to this report they have not contained multidrug resistance cassettes. In M. haemolytica, a partial ICE was identified by Michael et al. (21) in the draft genome sequence of PHL213, and a putative ICEMh1 was recently detected in M. haemolytica strain 42548, the latter harboring five resistance genes, aphA-1, strA, strB, sul2, and tetR-tetH (41), a less developed complement of resistance genes than that identified in the present study.
ICEPmu1 from P. multocida has been shown to undergo con- Further investigations into interspecies transfer of the ICE detected here, in particular transfer from BRD pathogens into enteric zoonotic or environmentally persistent species that thrive in fecal material and water bodies in feedlot environments, are important. Transfer of ICE into environmental isolates, such as those we coisolated with BRD pathogens (Actinobacter spp., Bacillus spp., Carnobacterium spp., and Psychrobacter spp.), could result in the dissemination of these elements into the broader environment, establishing a reservoir for their persistence. In addition, many veterinary and zoonotic pathogens are present in the feedlot environment, including Salmonella spp., Enterococcus spp., Campylobacter jejuni, E. coli, Yersinia enterocolitica, and Clostridium difficile. Potentially pathogenic species, including E. coli, Proteus mirabilis, Moraxella bovoculi, and Streptococcus uberis were identified in this study but not examined for antimicrobial resistance phenotypes. Multidrug resistance development in these organisms as a result of a single ICE transfer event could potentially have undesirable consequences for human health.
In this study, it was interesting that multidrug-resistant ICE were detected in a high proportion of the U.S. samples (88%) but not in the samples screened from Alberta. In the United States, the majority of feedlots contain more than 32,000 animals, with the five largest feeding operations controlling approximately 20% of feeding capacity. The average feedlot in Alberta or Saskatchewan contains approximately 8,000 head, with 64% of feedlots in Alberta having capacities of Ͻ20,000 head (42) . It is possible that larger, higher-density operations require more antimicrobial input to prevent disease. Likewise, the U.S. calves sampled were on average 250 lb lighter and on feed 17 days less than those in Alberta, indicating that they were likely considered high risk for developing BRD and targeted for metaphylactic treatment upon arrival.
It is important to note that BRD mortalities were targeted in this study and the cattle examined were likely exposed to more antimicrobial therapies than the general cattle population. Further, sample size was a limitation, and a larger surveillance project would be required to comment on the prevalence of ICE-harboring bacteria in North American cattle populations. Future investigations into antimicrobial resistance profiles of P. multocida, M. haemolytica, and H. somni from swine and poultry operations and at other levels of the beef production system, including cow-calf and various points during the marketing chain, would be advisable. Aarestrup et al. (43) estimated that swine and poultry account for about 34% and 33%, respectively, of the global livestock antimicrobial market, whereas cattle account for only 26%. The majority of ICE in this study could be coselected for through the use of florfenicol, enrofloxacin, tilmicosin, or tetracycline, all drugs used to prevent or treat BRD (27) but also approved for use in swine and poultry. Examination of the prevalence of ICE-harboring bacteria in the general feedlot population would be of benefit as rates of resistance have been shown to differ between healthy and sick populations of cattle (19) , and the high levels of resistance observed in mortality cases here may not be represent those of the general population.
To our knowledge, this is the first detection of ICE in M. haemolytica and H. somni from U.S. feedlots, and the very recent identification of ICEPmu1 (38) indicates that these elements may have recently emerged within the feedlot environment. In the current study, isolates of M. haemolytica were obtained that exhibited resistant phenotypes against all antimicrobials commonly employed to treat BRD, except ceftiofur. However, resistance to ceftiofur was observed in this study in an isolate of P. multocida and the potential incorporation of this undefined determinant into existing M. haemolytica could result in pathogenic isolates resistant to the entire suite of therapies commonly used to treat and prevent respiratory disease in feedlot cattle.
The identification of ICE elements in this study is new information that may affect our thought processes relative to how antimicrobials are used for BRD control and treatment. One hypothesis is that the presence or absence of ICE elements relates to antimicrobial use; however, in the current study the Alberta feedlots followed the same antimicrobial use protocols for BRD control and treatment as those in Nebraska. As such, continued research should be supported to investigate interspecies barriers for ICE transfer and to describe donor versus recipient range to provide more information about how features of these elements contribute to proliferation and spread. Further, comparative sequence analysis of these identified ICE is required to confirm gene arrangement, and may give insight into of the evolutionary development of these specific elements. If ICE elements were to become established in bacterial populations implicated in BRD, it could compromise the ability of prophylactic use of antimicrobials to control this important disease.
